Friday 6 November 2026
Export UHS’s income statement to Excel — free account
Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024.
- Revenue
- +5.30%
- EPS
- −9.98%
- Free cash flow
- +216.7%
- Total debt
- +21.7%
Quarter to September 2026, against a year earlier
194.62
3.97
−2.00%
Follow UHS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.29 | 7.36 | 5.99 | 7.19 |
P/S ratio |
0.80 | 0.62 | 0.49 | 0.56 | |
P/FCF ratio |
16.32 | 11.98 | 10.49 | 9.04 | |
P/Operating CF |
24.12 | 27.21 | 20.01 | 16.10 | |
P/B ratio |
1.89 | 1.45 | 1.17 | 144.30 | |
Price to Tangible BV |
4.14 | 3.08 | 2.46 | 0.00 | |
EV/Sales |
1.06 | 0.87 | 0.75 | 0.86 | |
EV/EBITDA |
7.07 | 5.82 | 5.03 | 5.85 | |
EV/Operating CF |
9.91 | 8.14 | 7.55 | 7.68 | |
EV/FCF |
21.76 | 17.00 | 16.07 | 13.92 | |
Quick Ratio |
0.85 | 0.88 | 0.89 | 1.11 | |
Current Ratio |
1.05 | 1.08 | 1.12 | 1.37 | |
Net Debt/EBITDA |
6.78 | 6.97 | 6.89 | 0.00 | |
Debt/Assets |
30.61% | 30.03% | 30.45% | 33.21% | |
Debt/Equity |
0.65 | 0.63 | 0.64 | 0.74 | |
Asset Turnover |
1.16 | 1.16 | 1.17 | 1.13 | |
Operating CF/Net income |
1.29 | 1.15 | 1.24 | 2.06 | |
Capex/Depreciation |
(1.61) | (1.40) | (1.36) | (1.23) | |
Interest Coverage |
12.25 | 13.54 | 12.95 | 8.08 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
45.62% | 46.45% | 46.15% | 46.70% | |
Intangible Assets out of Total Assets |
0.26 | 0.25 | 0.25 | 0.28 | |
Share Based Compensation of Revenue |
0.56% | 0.50% | 0.49% | 0.56% | |
Graham Net Nets |
(0.34) | (0.43) | (0.53) | (0.57) | |
Graham Number |
246.89 | 259.71 | 266.46 | 25.66 | |
Earnings Yield |
10.77% | 13.58% | 16.70% | 13.91% | |
Free Cash Flow Yield |
6.13% | 8.35% | 9.53% | 11.07% | |
Revenue per Share |
70.56 | 73.61 | 77.74 | 80.51 | |
Operating CF per Share |
9.04 | 6.58 | 7.43 | 10.83 | |
Capex per Share |
(4.13) | (3.56) | (3.82) | (3.66) | |
Free Cash Flow per Share |
4.91 | 3.02 | 3.62 | 7.17 | |
Cash per Share |
2.17 | 1.95 | 2.33 | 2.87 | |
Shareholders Equity per Share |
115.42 | 123.32 | 127.09 | 130.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
115.42 | 123.32 | 127.09 | 130.42 | |
Free Cash Flow |
312.15 | 184.47 | 215.67 | 421.61 | |
Working Capital |
168.31 | 255.62 | 381.67 | 992.81 | |
Capital Expenditures |
(262.54) | (217.16) | (227.63) | (214.94) | |
Net Current Asset Value |
(4,780.89) | (4,650.34) | (4,674.53) | (5,837.75) | |
EV/EBIT |
9.27 | 7.60 | 6.60 | 7.93 | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.05 | |
Price to Operating Income |
6.95 | 5.35 | 4.31 | 5.15 | |
| Other line items | |||||
Average Receivables |
2,390.09 | 2,578.31 | 2,551.68 | 2,699.52 | |
Average Payables |
1,524.14 | 2,224.40 | 2,324.41 | 2,426.93 | |
Average Inventory |
226.53 | 225.70 | 228.44 | 231.11 | |
Average Assets |
14,998.67 | 15,278.29 | 15,460.54 | 16,264.85 | |
Average Common Equity |
7,044.16 | 7,201.76 | 7,333.57 | 3,650.75 |
Columns are period end dates · fundamentals updated 2 Nov 2026